证券记录 · 已归档季度
GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
18被追踪持有人
—Δ持有人
202.41M持有股份
$13.88B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +1 | 941.63M | $119.04B | +5 | −3 |
| Q1 2026 | 176 | +4 | 930.86M | $129.53B | +6 | −3 |
| Q4 2025 | 171 | 0 | 1.00B | $122.89B | +1 | — |
| Q3 2025 | 23 | -1 | 603.99M | $67.03B | — | −2 |
| Q2 2025 | 22 | -1 | 560.26M | $62.11B | — | −1 |
| Q1 2025 | 20 | 0 | 255.31M | $28.60B | — | — |
| Q4 2024 | 20 | +1 | 270.33M | $24.97B | +1 | — |
| Q3 2024 | 18 | 0 | 213.42M | $17.89B | — | — |
| Q2 2024 | 18 | — | 202.41M | $13.88B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 76.25M | — | $5.23B | 0.9% | n/c | 1 | SEC ↗ |
| 2 | Dodge & Cox ✦ | 33.12M | — | $2.27B | 1.4% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 26.97M | — | $1.85B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 4 | Wellington Management ✦ | 22.94M | — | $1.57B | 0.3% | n/c | 1 | SEC ↗ ×8 |
| 5 | Norges Bank ✦ (被动) | 17.39M | — | $1.19B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 5.06M | — | $347.00M | 0.6% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 4.59M | — | $314.59M | 0.3% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 3.34M | — | $229.04M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 3.33M | — | $228.72M | 0.6% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 2.85M | — | $195.23M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 2.54M | — | $174.28M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 2.05M | — | $140.86M | 0.2% | n/c | 1 | SEC ↗ ×4 |
| 13 | Bridgewater Associates ✦ | 790.64K | — | $54.25M | 0.3% | n/c | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 512.12K | — | $35.14M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 281.45K | — | $19.31M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 278.39K | — | $19.10M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 120.52K | — | $8.27M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 13.20K | — | $905,965 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 61.30K 股份, $8,543 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 15
Mercier Johanna
Officer · 1.60K 股 · $229,907
Sep 15
Mercier Johanna
Officer · 600 股 · $87,174
Sep 15
Mercier Johanna
Officer · 800 股 · $115,566
Sep 15
Dickinson Andrew D
Officer · 3.00K 股 · $435,870
Sep 01
O'Day Daniel Patrick
Officer, Director · 7.99K 股 · $1.19M
Sep 01
O'Day Daniel Patrick
Officer, Director · 1.60K 股 · $236,014
Sep 01
O'Day Daniel Patrick
Officer, Director · 5.41K 股 · $807,856
Aug 26
WELTERS ANTHONY
Director · 3.40K 股 · $504,296
Aug 26
WELTERS ANTHONY
Director · 3.12K 股 · $462,432
Aug 26
WELTERS ANTHONY
Director · 4.60K 股 · $684,590
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据